David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$751M |
| 2 |
Advanced Micro Devices
AMD
|
+$751M |
| 3 |
Micron Technology
MU
|
+$426M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$363M |
| 5 |
ExxonMobil
XOM
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$546M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$485M |
| 3 |
VMW
VMware, Inc
VMW
|
+$393M |
| 4 |
Microsoft
MSFT
|
+$336M |
| 5 |
UnitedHealth
UNH
|
+$303M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.03% |
| 2 | Consumer Discretionary | 9.51% |
| 3 | Healthcare | 5.77% |
| 4 | Financials | 5.47% |
| 5 | Communication Services | 4.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HTB
2901
HomeTrust Bancshares
HTB
$771M
| $1.16M | ﹤0.01% |
42,966
+667
| +2% | +$15.3K |
|
|
RDFN
2902
DELISTED
Redfin
RDFN
| $1.16M | ﹤0.01% |
111,927
+56,876
| +103% | +$396K |
|
2903
Enovix
ENVX
$742M
| $1.15M | ﹤0.01% |
+105,088
| New | +$1.03M |
|
2904
Ouster
OUST
$2.61B
| $1.15M | ﹤0.01% |
+150,016
| New | +$786K |
|
2905
Flowers Foods
FLO
$1.51B
| $1.15M | ﹤0.01% |
51,044
-57,223
| -53% | -$1.23M |
|
2906
Charles River Laboratories
CRL
$14.2B
| $1.15M | ﹤0.01% |
4,857
+3,737
| +334% | +$735K |
|
2907
Victory Capital Holdings
VCTR
$7.09B
| $1.15M | ﹤0.01% |
+33,313
| New | +$1.07M |
|
2908
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$284M
| $1.14M | ﹤0.01% |
5,422
+3,798
| +234% | +$1.22M |
|
2909
CALL
Rapid7
RPD
$818M
| $1.14M | ﹤0.01% |
20,000
-62,900
| -76% | -$3.29M |
|
|
MODN
2910
DELISTED
MODEL N, INC.
MODN
| $1.14M | ﹤0.01% |
42,234
-10,518
| -20% | -$253K |
|
2911
MBIA
MBI
$250M
| $1.13M | ﹤0.01% |
185,248
+28,348
| +18% | +$228K |
|
2912
CALL
CNX Resources
CNX
$5.33B
| $1.13M | ﹤0.01% |
+56,600
| New | +$1.21M |
|
2913
Castle Biosciences
CSTL
$1.07B
| $1.13M | ﹤0.01% |
+52,364
| New | +$922K |
|
2914
CALL
Elastic
ESTC
$8.36B
| $1.13M | ﹤0.01% |
10,000
| – | – |
|
|
SASR
2915
DELISTED
Sandy Spring Bancorp Inc
SASR
| $1.12M | ﹤0.01% |
41,287
-29,501
| -42% | -$666K |
|
|
EWCZ
2916
DELISTED
European Wax Center
EWCZ
| $1.12M | ﹤0.01% |
82,731
+38,759
| +88% | +$561K |
|
|
ARIS
2917
DELISTED
Aris Water Solutions
ARIS
| $1.12M | ﹤0.01% |
+133,840
| New | +$1.15M |
|
2918
Kemper
KMPR
$1.64B
| $1.12M | ﹤0.01% |
+23,032
| New | +$1.01M |
|
2919
Compass Minerals
CMP
$1.03B
| $1.12M | ﹤0.01% |
44,259
+6,868
| +18% | +$175K |
|
|
CMA
2920
DELISTED
Comerica
CMA
| $1.12M | ﹤0.01% |
20,069
-52,730
| -72% | -$2.38M |
|
2921
Independent Bank Corp
IBCP
$815M
| $1.12M | ﹤0.01% |
42,936
-800
| -2% | -$17.1K |
|
2922
Invesco KBW Bank ETF
KBWB
$6.81B
| $1.12M | ﹤0.01% |
+22,697
| New | +$960K |
|
|
LX
2923
LexinFintech Holdings
LX
$214M
| $1.12M | ﹤0.01% |
606,489
-13,184
| -2% | -$25.3K |
|
2924
CALL
Brookfield Infrastructure
BIPC
$4.87B
| $1.11M | ﹤0.01% |
31,575
-68,623
| -68% | -$2.19M |
|
2925
PUT
Nokia
NOK
$57.8B
| $1.11M | ﹤0.01% |
325,500
| – | – |
|
Similar funds
David Shaw's Q4 2023 Portfolio in Review
As of Q4 2023, David Shaw held 4,806 positions worth $114B, up 19% from $95.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw's Q4 2023 filing shows 575 new, 1,549 increased, 1,464 reduced and 527 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $546M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q4 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M.
- David Shaw added most to Netflix in Q4 2023, an estimated $751M increase.
- David Shaw's biggest Q4 2023 reduction was Microsoft, cutting an estimated $336M.
- David Shaw fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $546M.
- David Shaw's ten largest holdings make up 12% of its $114B portfolio in Q4 2023.
- David Shaw opened 575 new positions and closed 527 in Q4 2023.
- David Shaw's portfolio value rose 19% quarter-over-quarter to $114B.
Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.